Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting-Reference-Cited by-同舟云学术

Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

Published:2015-06-02 Issue:1 Volume:90 Page:31-39
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Arroz Maria¹,Came Neil²,Lin Pei³,Chen Weina⁴,Yuan Constance⁵,Lagoo Anand⁶,Monreal Mariela⁷,de Tute Ruth⁸,Vergilio Jo-Anne⁹,Rawstron Andy C.⁸,Paiva Bruno¹⁰

Affiliation:

1. Department of Clinical Pathology; Cytometry Laboratory; CHLO, Hospital S. Francisco Xavier; Lisbon Portugal

2. Pathology Department; Peter MacCallum Cancer Centre; Melbourne Australia

3. Department of Hematopathology; MD Anderson Cancer Center; Houston Texas, USA

4. Department of Pathology; University of Texas Southwestern Medical Center; Dallas Texas, USA

5. Laboratory of Pathology; NCI, NIH; Bethesda Maryland, USA

6. Department of Pathology; Duke University Medical Center; Durham North Carolina, USA

7. Interpflow Corporation; Miami Florida, USA

8. HMDS, Department of Haematology, St. James's Institute of Oncology; Leeds United Kingdom

9. University Of Michigan Medical Center Hematology Oncology Laboratory; Ann Arbor Michigan, USA

10. Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, University of Navarra; Pamplona Spain

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cyto.b.21228/fullpdf

Reference30 articles.

1. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - Part III - analytical issues;Tanqri;Cytometry B Clin Cytom,2013

2. Report of the European Myeloma Network on multiparametric flow Cytometry in multiple myeloma and related disorders;Rawstron;Haematologica,2008

3. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes;Dongen;Leukemia,2012

4. Multiparameter immunophenotyping by flow cytometry in multiple myeloma; the diagnostic utility of defining ranges of normal antigenic expression in comparison to histology;Cannizzo;Cytometry B Clin Cytom,2010

5. Immunophenotypic heterogeneity of normal plasma cells: Comparison with minimal residual plasma cell myeloma;Liu;J Clin Pathol,2012

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon Regulatory Factor 4: An Alternative Marker for Plasma Cells in Daratumumab‐Treated Patients With Multiple Myeloma;International Journal of Laboratory Hematology;2024-09-12

2. Advances in estimating plasma cells in bone marrow: A comprehensive method review;African Journal of Laboratory Medicine;2024-07-11

3. Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry;Cytometry Part B: Clinical Cytometry;2024-06-14

4. Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry;Scientific Reports;2024-05-06

5. Characterization of Human B Cell Hematological Malignancies Using Protein-Based Approaches;International Journal of Molecular Sciences;2024-04-24